Publications by authors named "Hani Al Hashmi"

Claim this Profile
B
Brentuximab vedotin plus bendamustine versus platinum-based regimens as 1st salvage therapy and 'bridge' to autologous hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma.
Panayotis Kaloyannidis, Mohammed Al Zayer, Mohammed Al Darweesh, Majed Al Batran, Ayed Al Garni, Hani Al Hashmi

Leuk Lymphoma· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perception of blood donation among employees of healthcare organizations during COVID-19 pandemic: A national multicenter cross-sectional study.
Lubna Al Zadjali, Khalid Batarfi, Maha Badawi, Ghada Elgohary, Mansour Aljabry, Hani AlHashmi

Transfusion· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Assessment for Newly Diagnosed Fit Young Patients with Multiple Myeloma in the Era of Novel Treatment Modalities: Should There Be Additional Factors Taken into Consideration??
Panayotis Kaloyannidis, Fatema Abdulla, Enas Mutahar, Haidar Al Hashim, Salman Al Harbi, Hani Al Hashmi

J Blood Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical course and outcomes of COVID-19 in hematopoietic cell transplant patients, a regional report from the Middle East.
Riad El Fakih, Alfadil Haroon, Feras Alfraih, Murtadha K Al-Khabori, Mohsen Alzahrani, Hani Al Hashmi

Bone Marrow Transplant· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Clinical Applications and Future Perspectives of Immune Checkpoint Inhibitors in Non-Hodgkin Lymphoma.
John Apostolidis, Ayman Sayyed, Mohammed Darweesh, Panayotis Kaloyannidis, Hani Al Hashmi

J Immunol Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib for steroid refractory chronic graft-versus-host disease: therapeutic efficiency can be limited by increased risk of fungal infection.
Panayotis Kaloyannidis, Ahmed Ayyad, Zakaria Bahaliwah, Belal Blowi, Wael Alanazi, Hani Al Hashmi

Bone Marrow Transplant· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
Panayotis Kaloyannidis, Eshrak Al Shaibani, Asif Moinnudin, Khalid Al Anezi, Hani Al Hashmi

Hematol Rep· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Favorable Outcome After Adjuvant Involved-Field Radiotherapy After Autologous Hematopoietic Stem-Cell Transplantation in Patients With High-Risk Relapsed/Refractory Lymphoma: A Single-Center Experience.
Panayotis Kaloyannidis, Rawan Omari, Eman Eldebawy, Eshrak Al Shaibani, John Apostolidis, Hani Al Hashmi

Clin Lymphoma Myeloma Leuk· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Convalescent Plasma for Severe COVID-19: Interim Report of a Multicenter Phase II Study from Saudi Arabia.
Nawal AlShehry, Syed Ziauddin A Zaidi, Ahmed AlAskar, Abdurahman Al Odayani, Jawaher Mubarak Alotaibi, Hani Al-Hashmi

Saudi J Med Med Sci· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Convalescent Plasma to Treat Severe COVID-19: Protocol for the Saudi Collaborative Multicenter Phase II Study.
Mohammed Albalawi, Syed Ziauddin Ahmed Zaidi, Nawal AlShehry, Ahmed AlAskar, Abdul Rehman Zia Zaidi, Hani Al-Hashmi

JMIR Res Protoc· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TARGET: a survey of real-world management of chronic myeloid leukaemia across 33 countries.
Anna Turkina, Jianxiang Wang, Vikram Mathews, Guray Saydam, Chul Won Jung, Hani Hassan Al Hashmi

Br J Haematol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follicular lymphoma: Update on management and emerging therapies at the dawn of the new decade.
John Apostolidis, Nihad Mokhtar, Rawan Al Omari, Mohammed Darweesh, Hani Al Hashmi

Hematol Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up of Patients with Various Types of Lymphoma during the Coronavirus Disease 2019 Pandemic.
Musa Alzahrani, Mubarak M Al-Mansour, John Apostolidis, Ahmed Barefah, Reyad Dada, Hani Al-Hashmi

Saudi J Med Med Sci· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing hematopoietic stem cell transplant programs; overcoming cost through collaboration.
Hani Al-Hashmi, Ahmed Alsagheir, Analie Estanislao, Jenifer Bacal, Ashraf Alsuhebah

Bone Marrow Transplant· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing Cancer Treatment Shortages in Saudi Arabia: Results of a National Survey and Expert Panel Recommendations.
Aeshah A AlAzmi, Wasil Jastaniah, Hani S Alhamdan, Arwa O AlYamani, Waleed I AlKhudhyr, Hani Al-Hashmi

JCO Glob Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease.
Panayotis Kaloyannidis, Eshrak Al Shaibani, Ioannis Apostolidis, Solaf Kanfar, Khalid Al Anezi, Hani Al Hashmi

Bone Marrow Transplant· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends.
Helen Baldomero, Mahmoud Aljurf, Syed Z A Zaidi, Shahrukh K Hashmi, Ardeshir Ghavamzadeh, Hani Al-Hashmi

Bone Marrow Transplant· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De Novo Psoriasis Vulgaris Diagnosed after Nivolumab Treatment for Refractory Hodgkin's Lymphoma, Completely Resolved after Autologous Hematopoietic Stem Cell Transplantation.
Panayotis Kaloyannidis, Eshrak Al Shaibani, Miral Mashhour, Mohammed Gamil, Ioannis Apostolidis, Hani Al Hashmi

Case Rep Hematol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hodgkin Lymphoma Outcome: A Retrospective Study from 3 Tertiary Centers in Saudi Arabia.
Ruaa G Shafi, Mubarak M Al-Mansour, Solaf S Kanfar, Hani Al Hashmi, Ahmed Alsaeed

Oncol Res Treat· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis